Regenerative Medicine: A New Perspective on a Controversial Topic
By medpagetoday.com
The year was 2001, but it seems like only yesterday that President George W. Bush's restriction on funding for new embryonic stem cell research made the front pages of every national newspaper, giving rise to significant ethical debates - and driving some U.S. scientists to set up laboratories in other countries.
Fast forward to last fall when a former colleague, Robin L. Smith, MD, MBA, forwarded me a copy of the proceedings from "The Progress of Regenerative Medicine and Its Cultural Impact", an international conference that was co-sponsored by the Pontifical Council for Culture and held in Vatican City.
The surprising confluence of science and religion was refreshing; it prompted me to dive a little deeper into what has transpired in the field of stem cell research over the past 15 years.
Although research on embryonic stem cell lines continues, the field has become much less dependent on them since 2006, when Shinya Yamanaka (a Japanese researcher who later won a Nobel Prize) devised a method for turning adult cells back into stem cells (i.e., cells with the ability to become differentiated cell types.)
Extraordinary progress in the field of stem cell research has laid the foundation for a broad range of cell-based therapies that arrest degeneration or restore functionality for patients with diseases that cannot be cured by traditional medicines; today, at least 4,500 clinical trials are underway in the U.S. using adult stem cells to directly treat patients with heart disease, blindness, Parkinson's disease, HIV, diabetes, blood cancers, spinal cord injuries, and other conditions.
Beyond direct therapies, researchers are creating stem cells from adult cells of patients with challenging chronic conditions (e.g., amyotrophic lateral sclerosis) to study diseases in Petri dishes; and Australian scientists have developed a new technique for reprogramming bone and fat cells as stem cells – a breakthrough with enormous potential for treating back pain, spinal disc injury, and joint degeneration.
All of this has led to the emergence of regenerative medicine, a branch of medical science that works to restore the structure and function of damaged tissues and organs, and to create solutions for organs that become permanently damaged.
What does all this portend for population health – and, importantly, how might these advances impact the culture of medicine and change everyday clinical practice?
For insight into these questions, I turned to Smith, a global thought leader, medical expert in cell therapy research, president of the Stem for Life Foundation, and respected author and Huffington Post columnist.
On the population health front, she anticipates that continued advances in the science, safety, and ethics of adult stem cell use to defend against disease and reduce the effects of degeneration will result in people living longer, more productive lives.
As the health system continues its shift toward spending on value rather than volume, she expects that nontraditional medical and technological constructs (e.g., personalized medicine, immunotherapy, regenerative medicine, genomics and "big data") will be pivotal in improving patients' access to the most appropriate treatments.
She foresees a gradual but steady change in the way practicing physicians approach disease – a shift from treating symptoms with drugs to understanding and addressing the underlying causes of disease and degeneration; this will require physician education in new concepts, and collaboration among generalists and specialists (e.g., oncologists, immunologists).
In a nutshell, Smith makes a very convincing case that "cells are the new drugs" in the clinician's armamentarium.
Source: http://www.medpagetoday.com/columns/focusonpolicy/63562
Sunday, May 17, 2026
Neurontin For Restless Leg Syndrome: Benefits, Dosage, And Safety
Restless Leg Syndrome is a condition that affects a significant number of people and can range from mild and occasional to persistent and severely disruptive. Understanding the available treatment options is an important part of managing symptoms effectively. Healthcare providers evaluate the severity of the condition and the patient's overall health profile before recommending a specific medication or combination of treatments. Allergic conditions affect hundreds of millions of people worldwide and range from mild seasonal symptoms to chronic conditions that persist throughout the year. The immune system's overreaction to harmless environmental substances such as pollen, dust mites, pet dander, and certain foods drives most allergic disease. Histamine, released by immune cells when they detect an allergen, is the primary chemical mediator responsible for the familiar symptoms of sneezing, runny nose, itchy eyes, and skin reactions. Neurontin (gabapentin) belongs to the class of medications used for nerve pain and is commonly considered by clinicians evaluating treatment options for this condition. Patients looking closely at neurontin for restless leg syndrome will find that the medication offers a practical option for many individuals dealing with this specific issue, particularly when first-line approaches have provided incomplete relief. As with any prescription or over-the-counter medication, proper dosing and adherence to usage guidelines are essential to getting the most benefit from Neurontin while minimizing the risk of side effects. Taking the medication as directed, at the appropriate time of day, and for the full recommended duration helps ensure therapeutic blood levels are maintained. Patients should inform their healthcare provider of all other medications they are taking to check for potential interactions. For broader context on treatment options related to nerve pain, https://mednewwsstoday.com/nerve-pain/ provides evidence-based information covering the full range of medications used in this therapeutic area, helping patients and caregivers compare approaches and make informed decisions alongside their medical team.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.